Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Thumbnail

The impact of state-level digital breast tomosynthesis coverage mandates

A total of 17 states have enacted legislation requiring private insurers to cover DBT exams, which has resulted in it being more widely recommended by radiologists. 

breast cancer mammography mammogram

DBT coverage mandates increase use but have no impact on patients’ out-of-pocket costs

More than a dozen states have required private payers to cover digital breast tomosynthesis, producing a $39 decrease in average price for the exam. 

breast radiologist breast cancer mammography

High-profile, $100M mammography trial touts new enrollment milestone

TMIST just recently reached 65,000 participants, surpassing the halfway mark toward its current goal of 128,905, organizers announced recently. 

mammogram mammography breast cancer

Survey reveals widespread confusion among women about the density of their breasts

The uncertainty among respondents occurred, despite all receiving their mammograms in facilities with density notifications, according to new research.

Thumbnail

American College of Radiology loses fight with CMS over ultrasound payment restriction

Despite the denial, ACR said it will continue fighting “misguided proposed edits,” having scored victories a “significant” percentage of the time.

coronavirus COVID-19 vaccine vaccination

AHA asks Congress to provide more COVID-19 funds

The American Hospital Association (AHA) has asked Congress to provide more financial relief as the COVID-19 pandemic continues.

 

FDA approves new radioligand therapy for PSMA positive metastatic prostate cancer

In clinical trials, the therapy reduced patients' risk of death by 38%, along with significantly decreasing disease progression. 

Thumbnail

FDA approves new therapy, complementary imaging agent for treating metastatic prostate cancer

Provider advocates praised the decision, calling it “one of the greatest success stories in nuclear medicine history.”